2022
DOI: 10.1007/s12551-022-00944-8
|View full text |Cite
|
Sign up to set email alerts
|

Unraveling Cancer Metastatic Cascade Using Microfluidics-based Technologies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 194 publications
0
2
0
Order By: Relevance
“…68 The mesenchymal phenotype acquired through EMT enables cancer cells to navigate through the ECM and breach the basement membrane, prerequisites for entering the bloodstream. 69,70 Once in the bloodstream, these cells can be transported to distant sites in the body, initiating the formation of metastatic lesions. Utilizing a device that assesses endothelial barrier permeability, the platform demonstrates soluble biochemical factors such as TNF-α in conjunction with the presence of macrophages to enhance the intravascular penetration of cancer cells, while also influencing the interaction between tumor and endothelial cells.…”
Section: Intravasationmentioning
confidence: 99%
“…68 The mesenchymal phenotype acquired through EMT enables cancer cells to navigate through the ECM and breach the basement membrane, prerequisites for entering the bloodstream. 69,70 Once in the bloodstream, these cells can be transported to distant sites in the body, initiating the formation of metastatic lesions. Utilizing a device that assesses endothelial barrier permeability, the platform demonstrates soluble biochemical factors such as TNF-α in conjunction with the presence of macrophages to enhance the intravascular penetration of cancer cells, while also influencing the interaction between tumor and endothelial cells.…”
Section: Intravasationmentioning
confidence: 99%
“…These activities are influenced by tumor cell interactions with interstitial flow and diffusion of morphogens to the nearby microvascular network. A wide review is made on the recent developments with microfluidics to understand the cancer microenvironemnt undergoing metastatic cascade with microscopy by Hakim et al, and Del Piccolo et al 143 , 144 .…”
Section: Tumour Barriermentioning
confidence: 99%
“…Microfluidic organ-on-a-chip-based cell culture devices are valuable tools that enable co-culturing of 3D cell culture systems in a spatially controlled manner (e.g., controlled perfusion flow and gradient control of cytokines) to better simulate tissue and organ physiologies [23]. Microfluidic technology, with its unique characteristics, has become a promising tool in cancer research, especially for studying the metastasis process [46]. The details of each step in the metastasis process are not yet fully understood, and appropriate models are, therefore, needed to shed light on the complex multistep process.…”
Section: Microfluidic Organ-on-a-chip-based Cell Culture Devicesmentioning
confidence: 99%
“…The details of each step in the metastasis process are not yet fully understood, and appropriate models are, therefore, needed to shed light on the complex multistep process. For example, mouse models have been previously exploited to study the mechanism of metastasis, but animal models have also been challenged as they possess some disadvantages [46]. By mimicking the TME and angiogenesis, microfluidic platforms are used to study in vitro tumor growth, and the platforms are utilized for the detection and identification of CTCs with different phenotypes [46].…”
Section: Microfluidic Organ-on-a-chip-based Cell Culture Devicesmentioning
confidence: 99%